VCYT | Veracyte inc - Stock Value & PE Ratio Analysis

3

24

15

Good Growth

AI analysis rates VCYT with a higher value score of 4.
It is mainly due to adequate safety shown in the balance sheet.
Over the past 3 months, VCYT has maintained a consecutive value rating of 4.0, slightly higher than the rating of 3.5 over the past 3 years, indicating higher growth opportunities for enterprise value.
Compared to all stocks in the Health Care sector, VCYT has a higher value rating.

VCYT Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

Update to 2025/02/26 (Weekly Update)

VCYT Financial Forecast

Unit : USD

Update to 2025/5/4 (Quarterly Update)

VCYT Earnings Table

Unit : USD

QTR	Non-GAAP EPS	EPS YoY	EPS Surprise %	Sales	Sales YoY	Sales Surprise %	NPM
Current	0.36	1,000%	24.1%	118.63M	20.8%	7.1%	13.1%
2024Q2	0.19	733.3%	603.7%	115.86M	28.6%	-0.7%	5%
2023Q3	-0.02	81.8%	-89.5%	96.84M	17.5%	3.7%	-28.8%
2023Q2	-0.04	20%	-42.9%	98.2M	22.3%	6.8%	-32.9%
2023Q1	0.3	350%	530.8%	114.43M	26.7%	14.1%	-1.9%

Update to 2025/5/8 (Quarterly Update)

VCYT Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

VCYT Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry

Exit

The Backtest Result of VCYT from 2013/10 till Now

517.87%
Cumulative Return: 17.19%
Annual Return: 45.03%
Volatility: 0.38
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from October, 2013 to May, 2025. (Total Trades: 2)